The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers
Open Access
- 1 September 2003
- journal article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 81 (9) , 578-584
- https://doi.org/10.1007/s00109-003-0471-6
Abstract
Smoking and interleukin-6 are important factors in driving inflammation. This study assessed the relationship between smoking, interleukin-6 genotype, physical fitness, and peripheral blood count in healthy young men. For this interleukin-6 promoter polymorphism −174 genotype-phenotype association study 1,929 healthy German male aviators recruited at the central German Air Force Institute of Aviation Medicine were stratified by smoking habits. Cardiovascular fitness was expressed as maximal physical working capacity (PWCmax) in watts per kilogram body weight as assessed by maximal exercise testing by cycle ergometry up to physical exhaustion. Smokers had higher leukocyte and lymphocyte counts than nonsmokers and lower PWCmax. In the overall study population the C allele of the interleukin-6 polymorphism was weakly associated with elevated leukocytes and lymphocytes; in nonsmokers the interleukin-6 polymorphism was not associated with altered phenotypes, but in smokers the interleukin-6 C allele was associated with higher leukocytes, lymphocytes, and monocytes and with lower PWCmax. Smoking is thus associated with elevated leukocytes and lymphocytes and with reduced physical fitness. Gene carriers with the interleukin-6 C allele may suffer particularly from cigarette smoking.Keywords
This publication has 29 references indexed in Scilit:
- Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional Cardiovascular Risk Factors in WomenArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- The interleukin-6 G(–174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarctionJournal of Molecular Medicine, 2002
- Interleukin-6 −174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS)Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive proteinCardiovascular Research, 2002
- The interleukin-6 −174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy menEuropean Heart Journal, 2001
- Relation of the −174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularizationThe American Journal of Cardiology, 2001
- Interleukin-6 Gene −174G>C and −572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass SurgeryArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM studyJournal of Molecular Medicine, 2001
- Elevated Levels of Interleukin-6 in Unstable AnginaCirculation, 1996
- Inflammation and Coronary Artery DiseaseNew England Journal of Medicine, 1994